Bronchopleural communication following intrapleural doses of tPA/DNase for empyema
Abstract Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) therapy is a new treatment for pleural infection. Clinical experiences of tPA/DNase therapy, and its complications, are cumulating. We present a patient with multiloculated empyema but no initial evidence of a bro...
Main Authors: | Bapti Roy, Mark C. Teh, Yi Jin Kuok, Y. C. Gary Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Respirology Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/rcr2.646 |
Similar Items
-
Epidemiology, Etiology and Prevention of Postpneumonectomy Pleural Empyema
by: Danail B. Petrov, et al.
Published: (2019-09-01) -
Photodynamic therapy in tuberculous pleural empyema
by: S. D. Nikonov, et al.
Published: (2021-06-01) -
New therapy of pleural empyema by deoxyribonuclease
by: Grzegorz Kacprzak, et al.
Published: (2013-02-01) -
New therapy of pleural empyema by deoxyribonuclease
by: Grzegorz Kacprzak, et al. -
Intrapleural Tenecteplase Therapy in Treatment of Loculated Parapneumonic Pleural Effusions and Empyema
by: Alaa Refaat, et al.
Published: (2014-10-01)